Carlos Cordon-Cardo to Gene Expression Profiling
This is a "connection" page, showing publications Carlos Cordon-Cardo has written about Gene Expression Profiling.
Connection Strength
0.229
-
Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test. Prostate Cancer Prostatic Dis. 2018 11; 21(4):594-603.
Score: 0.080
-
Targeting sarcoma tumor-initiating cells through differentiation therapy. Stem Cell Res. 2017 05; 21:117-123.
Score: 0.073
-
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol. 2003 May 01; 21(9):1775-81.
Score: 0.028
-
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003 Jan; 34(1):54-64.
Score: 0.027
-
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR. Oncogene. 2018 11; 37(44):5858-5872.
Score: 0.020